SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-029337
Filing Date
2020-10-27
Accepted
2020-10-27 17:37:15
Documents
1
Period of Report
2020-10-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3963
  Complete submission text file 0000899243-20-029337.txt   5473
Mailing Address C/O ORCHARD THERAPEUTICS 101 SEAPORT BOULEVARD, 7TH FLOOR BOSTON MA 02210
Business Address
THOMAS FRANK E (Reporting) CIK: 0001242616 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38266 | Film No.: 201265306

Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Issuer) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations